<DOC>
	<DOCNO>NCT02196129</DOCNO>
	<brief_summary>The purpose study investigate immediate pain relieve effect sinbaro-3 pharmaco-acupuncture patient low back pain admit inpatient care</brief_summary>
	<brief_title>Immediate Pain Relieving Effects Sinbaro-3 Low Back Pain</brief_title>
	<detailed_description>60 patient LBP moderate severe pain ( NRS &gt; 6 ) randomly allocate 2 group . The experimental group treat sinbaro-3 pharmacoacupuncture control group treat Hwangryun pharmacoacupuncture . All administration limit 1 session , comparison measurement make treatment . Primary outcome measure use VAS scale . Post-treatment follow-up perform measure primary outcomes 30 minute , 2hours , 4hours , 6 hour treatment . Before measurement , patient ask stand rotate torso . At termination study , satisfaction level patient 's current status also collect .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<criteria>Patients admitted Korean Medicine hospital low back pain without radiculopathy Age 18 69 NRS score &gt; 6 day intervention Voluntary participation write consent give study consent form Diagnosis serious disease ( ) possible cause back pain malignancy , vertebral fracture , spinal infection , inflammatory spondylitis , cauda equina compression , etc . Prior diagnosis chronic disease ( ) could affect effectiveness interpretation treatment result cardiovascular disease , diabetic neuropathy , fibromyalgia , rheumatoid arthritis , Alzheimer 's disease , epilepsy , etc . Progressive neurologic deficit ( ) concurrent severe neurological symptom Unsuitable risk complication acupuncture treatment patient clot disorder , severe diabetes risk infection , serious cardiovascular disease , undergo anticoagulant treatment , etc . Under prescription corticosteroid , immunosuppressant drug , psychiatric medicine , medication consider unsuitable subject researcher Experience gastroenteric complication take NSAIDs currently undergo treatment digestive disorder During pregnancy suspect pregnancy Subjects consider unsuitable clinical trial researcher</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>low back pain</keyword>
	<keyword>pharmacoacupuncture</keyword>
	<keyword>sinbaro-3</keyword>
</DOC>